Announcements Trials

Browse Landscape

Phase

Phase 2 29 Phase 3 11 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 8 INDUSTRY 6 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Docetaxel 7 Radiotherapy 6 Vincristine 5 Etoposide 5 Cyclophosphamide 5 Cisplatin 5 Specimen Handling 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Gemcitabine 4 Doxorubicin 4 Carboplatin 4 Capecitabine 4 pembrolizumab 3 dexamethasone acetate 3 dexamethasone 21-phosphate 3 auricularum 3 Prednisone 3 Oxaliplatin 3 Methotrexate 3 Leucovorin 3 Fluorouracil 3 Dexamethasone 3 Cytarabine 3 Calcium Dobesilate 3 Surgical Procedures, Operative 2 Ramucirumab 2 Radiation 2 Pemetrexed 2 Mitomycin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NETWORK × Rituximab × Clear all

NCT02405676 2026-03-19

BNHL-2015

Children's Cancer Group, China

Phase 2/3 Active not recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡